# Niki BioSolutions, Inc. (APM) — merger [completed]
Source: SEC API (secapi.ai) · situation sit_62ba574e9b66730976fd · retrieved 2026-08-11T16:10:44.089Z

## Overview
Niki BioSolutions, Inc. (formerly Aptorum Group Limited) is a measuring and controlling devices company.

Aptorum Group Limited merged with DiamiR Biosciences Corp. pursuant to an Agreement and Plan of Merger dated July 14, 2025. The merger was consummated on July 20, 2026, with Aptorum effecting a domestication and changing its name to Niki BioSolutions, Inc., a Delaware corporation. Kira S. Sheinerman, a DiamiR shareholder, received 1,515,293 shares of Niki Common Stock (51.56% of outstanding shares) as non-cash merger consideration in exchange for her DiamiR shares. The Niki Common Stock is listed on the Nasdaq Capital Market under ticker symbol "NIKI."

## Terms
- Counterparty: DiamiR Biosciences Corp. · Consideration: stock · Stake: 51.56%

## Key dates
- Completed 2026-07-20

## Timeline
- 2026-07-24 · SCHEDULE 13D (0001213900-26-081416): SCHEDULE 13D - Niki BioSolutions, Inc. — *Niki BioSolutions, Inc. (formerly Aptorum Group Limited) is a measuring and controlling devices company.* Aptorum Group Limited merged with DiamiR Biosciences Corp. pursuant to an Agreement and Plan of Merger dated July 14, 2025. The merger was consummated on July 20, 2026, with Aptorum effecting a domestication and changing its name to Niki BioSolutions, Inc., a Delaware corporation. Kira S. Sheinerman, a DiamiR shareholder, received 1,515,293 shares of Niki Common Stock (51.56% of outstanding shares) as non-cash merger consideration in exchange for her DiamiR shares. The Niki Common Stock is listed on the Nasdaq Capital Market under ticker symbol "NIKI."
  https://www.sec.gov/Archives/edgar/data/1734005/0001213900-26-081416.txt

## Citations
- 0001213900-26-081416 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026081416